An Open-Label, Clinical Validation Study to Evaluate the Efficacy and Safetyof Unani Pharmacopoeial Formulation â?? Majun Boolus in Nisyan (Amnesia)

Central Council for Research in Unani Medicine CCRUM New Delhi0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

研究概览

暂无简介。

•The patients fulfilling the following inclusion criteria will be included in this study:
•1. Subjects of either sex in the age group 40-80 years.
•2. Subjects with MMSE score of 10-23 representing mild to moderate cognitive impairment.

•1. Clinical presentation and/or history of any significant organic neurological diseases including space occupying lesions, stroke, head injury, seizure, and mental retardation
•2. Subjects with impairment of speech, hearing and vision, which can impede the interview for MMSE and QOL assessment
•3. Known cases of hypothyroidism or hyperthyroidism
•4. Subjects with Vitamin B12 deficiency
•5. Subjects on Psychotropic Drugs
•6. Clinical presentation and/or history of a chronic disease that requires long-term treatment, e.g., DM, tuberculosis, HIV infection, syphilis, CVD, pulmonary disease, CKD, chronic liver disease, or any other serious and/or unstable medical condition that, in the opinion of the investigator, could expose the patients to undue risk of a significant adverse event or interfere with assessment of safety or efficacy during the course of the trial
•7. Pregnant and lactating females
•8. H/o Addiction (alcohol, drugs)

发起方

Central Council for Research in Unani Medicine CCRUM New Delhi